These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25555446)

  • 1. Which treatment is better? Ascertaining patient preferences with crossover randomized controlled trials.
    Hui D; Zhukovsky DS; Bruera E
    J Pain Symptom Manage; 2015 Mar; 49(3):625-31. PubMed ID: 25555446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.
    Anglemyer A; Horvath HT; Bero L
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):MR000034. PubMed ID: 24782322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical research in palliative care: choice of trial design.
    Mazzocato C; Sweeney C; Bruera E
    Palliat Med; 2001 May; 15(3):261-4. PubMed ID: 11407200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials.
    King M; Nazareth I; Lampe F; Bower P; Chandler M; Morou M; Sibbald B; Lai R
    Health Technol Assess; 2005 Sep; 9(35):1-186, iii-iv. PubMed ID: 16153352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cluster randomized crossover trial: The effects of attrition in the AB/BA design and how to account for it in sample size calculations.
    Moerbeek M
    Clin Trials; 2020 Aug; 17(4):420-429. PubMed ID: 32191129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: the case of palliative care.
    Nikles J; Mitchell GK; Schluter P; Good P; Hardy J; Rowett D; Shelby-James T; Vohra S; Currow D
    J Clin Epidemiol; 2011 May; 64(5):471-80. PubMed ID: 20933365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and analysis of a 2-year parallel follow-up of repeated ivermectin mass drug administrations for control of malaria: Small sample considerations for cluster-randomized trials with count data.
    Jackson CL; Colborn K; Gao D; Rao S; Slater HC; Parikh S; Foy BD; Kittelson J
    Clin Trials; 2021 Oct; 18(5):582-593. PubMed ID: 34218684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine for treating cancer pain.
    Schmidt-Hansen M; Bromham N; Taubert M; Arnold S; Hilgart JS
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009596. PubMed ID: 25826743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, placebo-controlled, parallel group versus crossover study designs for the study of dementia in Parkinson's disease.
    Putt ME; Ravina B
    Control Clin Trials; 2002 Apr; 23(2):111-26. PubMed ID: 11943439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Aggregated N-of-1 Trials with Parallel and Crossover Randomized Controlled Trials Using Simulation Studies.
    Blackston JW; Chapple AG; McGree JM; McDonald S; Nikles J
    Healthcare (Basel); 2019 Nov; 7(4):. PubMed ID: 31698799
    [No Abstract]   [Full Text] [Related]  

  • 14. A practical Bayesian stepped wedge design for community-based cluster-randomized clinical trials: The British Columbia Telehealth Trial.
    Cunanan KM; Carlin BP; Peterson KA
    Clin Trials; 2016 Dec; 13(6):641-650. PubMed ID: 27430710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, analysis, and presentation of crossover trials.
    Mills EJ; Chan AW; Wu P; Vail A; Guyatt GH; Altman DG
    Trials; 2009 Apr; 10():27. PubMed ID: 19405975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for infantile seborrhoeic dermatitis (including cradle cap).
    Victoire A; Magin P; Coughlan J; van Driel ML
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011380. PubMed ID: 30828791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of heterogeneity on HIV prevention trials.
    Auvert B; Sitta R; Zarca K; Mahiane SG; Pretorius C; Lissouba P
    Clin Trials; 2011 Apr; 8(2):144-54. PubMed ID: 21478327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical approaches for design and analysis of clinical trials of infertility treatments: crossover designs and the Mantel-Haenszel method are recommended.
    Takada M; Sozu T; Sato T
    Pharm Stat; 2015; 14(3):198-204. PubMed ID: 25776032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.